Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/57415
Title: Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy.
Authors: 
Keywords: 
Mesh: 
Issue Date: 8-Nov-2021
Citation: BMC Infect Dis.2021;(21)1:1144
Abstract: Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection. This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records. Our primary endpoint was all-cause in-hospital mortality according to antibiotic use. The secondary endpoint was the effect of macrolides on mortality. Of 13,932 patients, antibiotics were used in 12,238. The overall death rate was 20.7% and higher among those taking antibiotics (87.8%). Higher mortality was observed with use of all antibiotics (OR 1.40, 95% CI 1.21-1.62; p  Bacterial co-infection was uncommon among COVID-19 patients, yet use of antibiotics was high. There is insufficient evidence to support widespread use of empiric antibiotics in these patients. Most may not require empiric treatment and if they do, there is promising evidence regarding azithromycin as a potential COVID-19 treatment.
URI: https://hdl.handle.net/20.500.12530/57415
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Cristina > Artículos

Files in This Item:
File SizeFormat 
PMC8575150.pdf1.2 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons